280 related articles for article (PubMed ID: 33185155)
1. Metallodrugs for the Treatment of Trypanosomatid Diseases: Recent Advances and New Insights.
Navarro M; Justo RMS; Delgado GYS; Visbal G
Curr Pharm Des; 2021; 27(15):1763-1789. PubMed ID: 33185155
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
Orosco D; Mendoza AR; Meléndez CM
Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
[TBL] [Abstract][Full Text] [Related]
3. Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases.
Ravera M; Moreno-Viguri E; Paucar R; Pérez-Silanes S; Gabano E
Eur J Med Chem; 2018 Jul; 155():459-482. PubMed ID: 29908440
[TBL] [Abstract][Full Text] [Related]
4. Aminoacyl-tRNA synthetase (AARS) as an attractive drug target in neglected tropical trypanosomatid diseases-Leishmaniasis, Human African Trypanosomiasis and Chagas disease.
Kushwaha V; Capalash N
Mol Biochem Parasitol; 2022 Sep; 251():111510. PubMed ID: 35988745
[TBL] [Abstract][Full Text] [Related]
5. Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases.
Henriquez-Figuereo A; Morán-Serradilla C; Angulo-Elizari E; Sanmartín C; Plano D
Eur J Med Chem; 2023 Jan; 246():115002. PubMed ID: 36493616
[TBL] [Abstract][Full Text] [Related]
6. Metal Compounds in the Development of Antiparasitic Agents: Rational Design from Basic Chemistry to the Clinic.
Gambino D; Otero Á L
Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855114
[TBL] [Abstract][Full Text] [Related]
7. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
[TBL] [Abstract][Full Text] [Related]
8. Proteasome as a Drug Target in Trypanosomatid Diseases.
Silva ML; de Santiago-Silva KM; Fabris M; Camargo PG; de Lima Ferreira Bispo M
Curr Drug Targets; 2023; 24(10):781-789. PubMed ID: 37469152
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Potential of Flavonoid Derivatives for Certain Neglected Tropical Diseases.
Pone BK; Ferreira EI
Curr Drug Targets; 2022; 23(7):680-682. PubMed ID: 35264087
[TBL] [Abstract][Full Text] [Related]
10. Application of Dithiocarbamates as Potential New Antitrypanosomatids-Drugs: Approach Chemistry, Functional and Biological.
Oliveira JWF; Rocha HAO; de Medeiros WMTQ; Silva MS
Molecules; 2019 Aug; 24(15):. PubMed ID: 31374887
[TBL] [Abstract][Full Text] [Related]
11. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
12. Systematic study of 1,2,3-triazolyl sterols for the development of new drugs against parasitic Neglected Tropical Diseases.
Porta EOJ; Ballari MS; Carlucci R; Wilkinson S; Ma G; Tekwani BL; Labadie GR
Eur J Med Chem; 2023 Jun; 254():115378. PubMed ID: 37084599
[TBL] [Abstract][Full Text] [Related]
13. Dual Inhibition of Parasitic Targets: A Valuable Strategy to Treat Malaria and Neglected Tropical Diseases.
Previti S; Di Chio C; Ettari R; Zappalà M
Curr Med Chem; 2022; 29(17):2952-2978. PubMed ID: 34375176
[TBL] [Abstract][Full Text] [Related]
14. Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.
Bastos IM; Motta FN; Grellier P; Santana JM
Curr Med Chem; 2013; 20(25):3103-15. PubMed ID: 23514419
[TBL] [Abstract][Full Text] [Related]
15. Anti-trypanosomatid drug discovery: progress and challenges.
De Rycker M; Wyllie S; Horn D; Read KD; Gilbert IH
Nat Rev Microbiol; 2023 Jan; 21(1):35-50. PubMed ID: 35995950
[TBL] [Abstract][Full Text] [Related]
16. Targeting cysteine proteases in trypanosomatid disease drug discovery.
Ferreira LG; Andricopulo AD
Pharmacol Ther; 2017 Dec; 180():49-61. PubMed ID: 28579388
[TBL] [Abstract][Full Text] [Related]
17. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
González M; Cerecetto H
Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
[TBL] [Abstract][Full Text] [Related]
18. Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases.
Nascimento IJDS; Cavalcanti MAT; de Moura RO
Eur J Med Chem; 2023 Oct; 258():115550. PubMed ID: 37336067
[TBL] [Abstract][Full Text] [Related]
19. Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis.
Sánchez-Delgado RA; Anzellotti A
Mini Rev Med Chem; 2004 Jan; 4(1):23-30. PubMed ID: 14754440
[TBL] [Abstract][Full Text] [Related]
20. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
